IntelGenx Corp. announced that it has entered into a Feasibility Study Agreement with an undisclosed partner (the Partner) focused on bringing innovative animal health products to the market. Pursuant to the Agreement, IntelGenx will conduct a feasibility study on an undisclosed molecule for buccal absorption using IntelGenx’s proprietary VetaFilm platform. Based on successful feasibility, IntelGenx will have exclusive rights to further develop, manufacture and supply the developed product to the Partner.